DONCASTER and Bassetlaw Teaching Hospitals has been named as one of just four NHS sites in England selected to test a new ...

Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for ...

A local radio host is encouraging Tucsonans to consider genetic testing after it played a critical role in her own health ...

For pediatric neurology patients, there are marked ethnoracial disparities in genetic testing completion, according ...

Highlights,Institutional investors adjusted their holdings in Myriad Genetics, signaling market engagement.,The company’s ...

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have earned a consensus recommendation of “Hold” from the fourteen analysts that are covering the company, MarketBeat reports. Three ...

Fintel reports that on February 12, 2025, Craig-Hallum initiated coverage of Myriad Genetics (NasdaqGS:MYGN) with a Buy ...

As previously reported, Craig-Hallum initiated coverage of Myriad Genetics (MYGN) with a Buy rating and $29 price target. The firm believes the ...

Myriad Genetics entered into an agreement with CancerCARE for Life to provide individuals within the latter's network with access to the MyRisk Hereditary Cancer Test.

KBC Group NV raised its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 132.8% in the fourth quarter, ...

Storm "took a lot of abuse" as a young female sports journalist. Last year, she was stunned by a breast cancer diagnosis.